News and Comments

The Sky’s The Limit For Micromet’s BiTE Technology’s Capability

  Tuesday, July 19, 2011

Micromet (MITI) added another important collaborator, Amgen (AMGN), to a long list of large and small drug developing companies that are attracted to Micromet’s BiTE technology. Amgen/Micromet agreement looks fair for both. It fits Amgen’s strategy of focusing on adding next-generation products to its pipeline and helps Micromet’s financial requirements during the development of its promising proprietary cancer programs. Amgen wanted to select from among three BiTE-based drugs against three undisclosed solid tumor targets. The giant biotech will pay upfront, milestone, and other payments in a deal that could be worth over $900 million for the two selected drugs, or half of this amount if it selects only one drug, in addition to double-digit royalties in the event of approvals and sales. More...

Recent Postings



Array Pharmaceuticals (ARRY) Ionis (IONS) Intermune (ITMN) Human Longevity (HLI) Theravance (THRX) Ridaforolimus Amgen (AMGN) ARCA (ABIO) Sarepta (SRPT) ABBVIE (ABBV) Roche (RHHBY) GlaxoSmithKline (GSK) Galena (GALE) Incyte (INCY) Cytokinetics (CYTK) HALOZYME (HALO) Rapamune KERYX (KERX) Seattle Genetics (SGEN) Jazz Pharmaceuticals (JAZZ) C4 Therapeutics Gilead (GILD) AGOS (ARGS) Ariad (ARIA) Dynavax (DVAX) Sangamo (SGMO) Benlysta (belimumab) Genentech KITE (KITE) AERIE PHARMACEUTICALS Alnylam (ALNY) GUARDIAN HEALTH SERES THERAPEUTICS (MCRB) REGULUS (RGLS) Herceptin Intercept (ICPT) Alder Biopharmaceuticals (ALDR) CompuGen (CGEN) SYNTA (SNTA) Endometrial Cancer Auspex (ASPX) Editas (EDIT) Zerenex Sanofi (SNY) Dendreon (DNDN) Trastuzumab-DM1 Vitae Pharmaceuticals (VTAE) ZALTRAP™ Intrexon (XON) Sanofi-Aventis (SAN) NEKTAR (NKTR)) SUNESIS PHARMACEUTICALS (SNSS) BIOMARIN (BMRN) Merck (MRK) Pluristem (PSTI) ImmunoGen (IMGN) Abbott Laboratories (ABT) Spike Therapeutics (ONCE) Velcade (bortezomib) IDERA (IDRA) JUNO (JUNO) Tysabri Elan (ELN) OSI (OSIP) Bristol-Myers Squibb (BMY) Anadys (ANDS) ISIS (ISIS) PTC Therapeutics (PTCT) Regeneron (REGN) ACADIA (ACAD) Prosensa (RNA) Mirati Therapeutics (MRTX) Telaprevir Prolor Biotech (PBTH) Ziofpharm (ZIOP) TOKAI (TKAOI) Vertex (VRTX) Biogen Idec (BIIB) Agenus (AGEN) Sequenom (SQNM) Global Cell Therapeutics (GBT) NANTKWEST (NK) Roche (ROCHE) RenenxBio (RGNX) Exelixis (EXEL) INNOVIVA (INVA) Biocryst (BCRX) galapagos (GLPG) Multiple Myeloma Onyx (ONXX) Micromet (MITI) Inovio (INO) Human Genome Sciences (HGSI) Revlimid (lenolidamide) Aimmune Therapeutics (AIMT) ARGOS (ARGS) Agenus (AGEN Illumina (ILMN) VANDA (VNDA) Idenix (IDIX) Valeant Pharmaceuticals International (VRX) Anacor (ANAC) ADVENTRIX (ANX) Xoma (XOMA) Sanofi (SNA) Theravance Bio Pharma (TBPH)